Peptide immunogens used as components of vaccine composition against covid-19
RU2743595C1
Vaccine composition against covid-19
RU2743593C1
Peptide immunogens and vaccine composition against covid-19 with the use of peptide immunogens
RU2738081C1
Peptide immunogens and a vaccine composition against coronavirus infection covid-19 using peptide immunogens
RU2747018C1
Sars-cov-2 coronavirus replication inhibitor based on melanin from inonotus obliquus fungus
RU2741714C1
Sars-cov-2 replication inhibitor based on a water extract of the fungus inonotus obliquus
RU2733834C1
Artificial ectos_sc2 gene encoding an ectodomain of the sars-cov-2 coronavirus s glycoprotein with a c-terminal trimerization domain, a recombinant plasmid pstem-rvsv-ectos_sc2, which provides expression of the artificial gene, and a recombinant strain of vesicular stomatitis virus rvsv-ectos_sc2, used to create a vaccine against sars-cov-2 coronavirus
RU2733832C1
Artificial gene stbl_rbd_trm_sc2, coding a bicistronic structure formed by the sars-cov-2 coronavirus glycoprotein s receptor-binding domain sequences, transmembrane region, p2a-peptide and glycoprotein g vsv, recombinant plasmid pstem-rvsv-stbl_rbd_trm_sc2, providing expression of artificial gene, and a recombinant strain of vesicular stomatitis virus rvsv-stbl_rbd_trm_sc2, used to create a vaccine against sars-cov-2 coronavirus
RU2733665C1
Set of oligodeoxyribonucletide primers and fluorescent-labeled probe for identification of rna of human coronaviruses sars and 2019-ncov by rt-pcr method with hybridization-fluorescent detection in real time
RU2742511C1
RECOMBITANT PLASMID DNA pET21-VP40VE CONTAINING THE GENE FOR THE MATRIX PROTEIN VP40 OF EBOLA VIRUS AND THE RECOMBITANT PROTEIN VP40-VE OBTAINED AS A RESULT OF THE GENE EXPRESSION FOR THE PROTEIN VP40 OF EBOLA VIRUS USING THE RECOMBITANT PLASMID DNA pET21-VP40VE AND EXHIBITING IMMUNOGENIC AND ANTIGENIC PROPERTIES
RU2739505C1
Recombinant plasmid dna pet21-npve containing nucleoloprotein (np) gene of ebola virus and recombinant protein np-ve, obtained as result of expression of np gene of ebola virus using recombinant plasmid dna pet21-npve and possessing immunogenic and antigenic properties
RU2717993C1
Method of producing antigen of zika virus, having immunogenic and antigenic properties
RU2716590C1
Strain of basidiomycete inonotus obliquus - producer of melanin pigment possessing antiviral and antitumoral activity
RU2716709C1
Oral dosage form of the preparation in capsules for treating and preventing orthopoxvirus-related diseases
RU2707631C1
Artificial nutrient medium for gypsy moth caterpillars (lymantria dispar l.) cultivation
RU2712149C1
Kit for differentiated detection of blood serum markers at all stages of infectious disease by multiparametric dot-immunoassay
RU2708556C1
RECOMBINANT PLASMID DNA p280_2GM CODING POLYPEPTIDE WITH PROPERTIES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR OF HUMAN, STRAIN ESCHERICHIA COLI SG 20050/p280_2GM - PRODUCER OF POLYPEPTIDE WITH PROPERTIES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR OF HUMAN AND METHOD OF OBTAINING OF SAID POLYPEPTIDE
RU2713723C1
ARTIFICIAL GENES CODING EV.CTL AND EV.Th PROTEINS-IMMUNOGENS, RECOMBINANT PLASMID DNA pEV.CTL AND EV.Th, PROVIDING EXPRESSION OF ARTIFICIAL GENES, AND ARTIFICIAL T-CELL POLYEPITOPE PROTEINS-IMMUNOGENS EV.CTL AND EV.Th CONTAINING EPITOPES OF EBOLA VIRUS ANTIGENS, USED TO CREATE AN EBOLA VIRUS VACCINE
RU2703826C1
Serum-free nutrient medium for culturing mdck or vero cells or vaccine strains of measles or influenza viruses
RU2706429C1
Method of determining complex permittivity of a biological cell in suspension
